News

Dr. Suri is a clinician-scientist at McGill University specializing in hemodialysis research. Her work focuses on behaviour-based interventions for people undergoing hemodialysis.

The Kidney Foundation of Canada (KFOC) is proud to announce a new research partnership with the Alport Syndrome Foundation (ASF) that advances our shared commitment to patient-driven kidney research and meaningful change for people living with rare kidney diseases.

The Kidney Foundation of Canada is excited to announce a new research partnership with the Hyatt Family Foundation to support innovation in kidney care.

Over a career spanning more than 25 years, Dr. Tomoko Takano has won the respect and gratitude of her peers and patients for her steadfast commitment to advancing understanding and treatment of kidney disease.

Protecting the long-term health of their heart and kidneys is a major challenge for people with type 1 diabetes (T1D). Luckily, findings from the SUGARNSALT project demonstrate medications that can help with this.

A patient’s journey on dialysis can be difficult not just physically but mentally and emotionally as well.

For over 25 years, Dr. Tomoko Takano has been a leader in the Canadian nephrology research community.

Indigenous peoples in Canada experience kidney disease and kidney failure up to four times more than the general population.

From astrophysics to kidney health, Dr. Morteza Ahmadi shares his journey going from a graduate student in black hole physics to KRESCENT Fellow to the founder of a start-up biotechnology company, Qidni Labs, centered on transforming dialysis care.

The Kidney Foundation of Canada extends a warm congratulations to Dr. Amit Garg, a nephrologist at the London Health Sciences Centre (LHSC), and his team for publishing the results of their clinical trial study in Kidney International, the highest impact journal for kidney research.

The STrategic Optimization of Prescription Medication Use in Patients on HemoDialysis (STOPMed-HD) research program has been working hard since 2016 to design a deprescribing intervention to aid clinicians and educate patients.

The Kidney Foundation of Canada would like to extend a huge congratulations to Dr. Janine Farragher for being awarded as Canada Research Chair (Tier 2) in Life Participation and Kidney Disease.